Immunotherapy of hepatoma with a monoclonal antibody against murine endoglin

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 17

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

249

HTML

1492

Figures (1-5)

192

Sum=1933

May 7, 2007 (publication date) through Nov 4, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. May 7, 2007; 13(17): 2479-2483
Published online May 7, 2007. doi: 10.3748/wjg.v13.i17.2479

Full Size Figure Download Figure

Figure 2 The survival rates at different time-points in Hepal-6 (A) and H22 (B) models. Log-rank test, P < 0.01, n = 10 in each group.

Citation: Tan GH, Huang FY, Wang H, Huang YH, Lin YY, Li YN. Immunotherapy of hepatoma with a monoclonal antibody against murine endoglin. World J Gastroenterol 2007; 13(17): 2479-2483
URL: https://www.wjgnet.com/1007-9327/full/v13/i17/2479.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i17.2479